Rapid, concurrent alterations in pre- and postsynaptic structure induced by naturally-secreted amyloid-β protein

Molecular and Cellular Neuroscience

Volumn 35, Issue 2, 2007, Pages 183-193

  Calabrese, Barbara ^a   Shaked, Gideon M ^b   Tabarean, Iustin V ^a   Braga, Julia ^a   Koo, Edward H ^b   Halpain, Shelley ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AMYLOID BETA PROTEIN; N METHYL DEXTRO ASPARTIC ACID RECEPTOR BLOCKING AGENT; NICOTINIC RECEPTOR;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN NERVE CELL; CELL CULTURE; CELL STRUCTURE; CONTROLLED STUDY; DENDRITE; GABAERGIC TRANSMISSION; HIPPOCAMPUS; NERVE ENDING; NONHUMAN; POSTSYNAPTIC MEMBRANE; PRIORITY JOURNAL; PROTEIN SECRETION; SYNAPSE VESICLE; SYNAPTIC POTENTIAL;

AMYLOID BETA-PROTEIN; AMYLOID BETA-PROTEIN PRECURSOR; ANIMALS; ANTIBODIES; AXONS; CELLS, CULTURED; CHOLINERGIC ANTAGONISTS; CRICETINAE; CRICETULUS; DENDRITES; EXCITATORY AMINO ACID ANTAGONISTS; EXCITATORY POSTSYNAPTIC POTENTIALS; GREEN FLUORESCENT PROTEINS; HIPPOCAMPUS; MICE; MUTATION; NERVE TISSUE PROTEINS; NEURONS; PATCH-CLAMP TECHNIQUES; SYNAPSES; TRANSFECTION;

ANIMALIA;

EID: 34249696007     PISSN: 10447431     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mcn.2007.02.006     Document Type: Article

References (47)

1. Baloyannis S.J., Manolidis S.L., and Manolidis L.S. The acoustic cortex in Alzheimer's disease. Acta Otolaryngol. Suppl. 494 (1992) 1-13
2. Bateman R.J., Munsell L.Y., Morris J.C., Swarm R., Yarasheski K.E., and Holtzman D.M. Human amyloid-beta synthesis and clearance rates as measured in cerebrospinal fluid in vivo. Nat. Med. 12 (2006) 856-861
3. Bell K.F., Ducatenzeiler A., Ribeiro-da-Silva A., Duff K., Bennett D.A., and Claudio Cuello A. The amyloid pathology progresses in a neurotransmitter-specific manner. Neurobiol. Aging 27 (2006) 1644-1657
4. Blanpied T.A., and Ehlers M.D. Microanatomy of dendritic spines: emerging principles of synaptic pathology in psychiatric and neurological disease. Biol. Psychiatry 55 (2004) 1121-1127
5. Calabrese B., and Halpain S. Essential role for the PKC target MARCKS in maintaining dendritic spine morphology. Neuron 48 (2005) 77-90
6. Cleary J.P., Walsh D.M., Hofmeister J.J., Shankar G.M., Kuskowski M.A., Selkoe D.J., and Ashe K.H. Natural oligomers of the amyloid-beta protein specifically disrupt cognitive function. Nat. Neurosci. 8 (2005) 79-84
7. D'Andrea M.R., and Nagele R.G. Targeting the alpha 7 nicotinic acetylcholine receptor to reduce amyloid accumulation in Alzheimer's disease pyramidal neurons. Curr. Pharm. Des. 12 (2006) 677-684
8. Davidsson P., and Blennow K. Neurochemical dissection of synaptic pathology in Alzheimer's disease. Int. Psychogeriatr. 10 (1998) 11-23
9. Deshpande A., Mina E., Glabe C., and Busciglio J. Different conformations of amyloid beta induce neurotoxicity by distinct mechanisms in human cortical neurons. J. Neurosci. 26 (2006) 6011-6018
10. Dunaevsky A., Tashiro A., Majewska A., Mason C., and Yuste R. Developmental regulation of spine motility in the mammalian central nervous system. Proc. Natl. Acad. Sci. U. S. A. 96 (1999) 13438-13443
11. Einstein G., Buranosky R., and Crain B.J. Dendritic pathology of granule cells in Alzheimer's disease is unrelated to neuritic plaques. J. Neurosci. 14 (1994) 5077-5088
12. Ferrer I., and Gullotta F. Down's syndrome and Alzheimer's disease: dendritic spine counts in the hippocampus. Acta Neuropathol. (Berl.) 79 (1990) 680-685
13. Fischer M., Kaech S., Knutti D., and Matus A. Rapid actin-based plasticity in dendritic spines. Neuron 20 (1998) 847-854
14. Hsieh H., Boehm J., Sato C., Iwatsubo T., Tomita T., Sisodia S., and Malinow R. AMPAR removal underlies Abeta-induced synaptic depression and dendritic spine loss. Neuron 52 (2006) 831-843
15. Ishibashi K., Tomiyama T., Nishitsuji K., Hara M., and Mori H. Absence of synaptophysin near cortical neurons containing oligomer Abeta in Alzheimer's disease brain. J. Neurosci. Res. 84 (2006) 632-636
16. Jacobsen J.S., Wu C.C., Redwine J.M., Comery T.A., Arias R., Bowlby M., Martone R., Morrison J.H., Pangalos M.N., Reinhart P.H., and Bloom F.E. Early-onset behavioral and synaptic deficits in a mouse model of Alzheimer's disease. Proc. Natl. Acad. Sci. U. S. A. 103 (2006) 5161-5166
17. Kohrmann M., Haubensak W., Hemraj I., Kaether C., Lessmann V.J., and Kiebler M.A. Fast, convenient, and effective method to transiently transfect primary hippocampal neurons. J. Neurosci. Res. 58 (1999) 831-835
18. Koo E.H., and Squazzo S.L. Evidence that production and release of amyloid beta-protein involves the endocytic pathway. J. Biol. Chem. 269 (1994) 17386-17389
19. Lacor P.N., Buniel M.C., Chang L., Fernandez S.J., Gong Y., Viola K.L., Lambert M.P., Velasco P.T., Bigio E.H., Finch C.E., Krafft G.A., and Klein W.L. Synaptic targeting by Alzheimer's-related amyloid beta oligomers. J. Neurosci. 24 (2004) 10191-10200
20. Lacor P.N., Buniel M.C., Furlow P.W., Sanz Clemente A., Velasco P.T., Wood M., Viola K.L., and Klein W.L. A{beta} Oligomer-induced aberrations in synapse composition, shape, and density provide a molecular basis for loss of connectivity in Alzheimer's Disease. J. Neurosci. 27 (2007) 796-807
21. Lanz T.A., Carter D.B., and Merchant K.M. Dendritic spine loss in the hippocampus of young PDAPP and Tg2576 mice and its prevention by the ApoE2 genotype. Neurobiol. Dis. 13 (2003) 246-253
22. Levites Y., Das P., Price R.W., Rochette M.J., Kostura L.A., McGowan E.M., Murphy M.P., and Golde T.E. Anti-Abeta42-and anti-Abeta40-specific mAbs attenuate amyloid deposition in an Alzheimer disease mouse model. J. Clin. Invest. 116 (2006) 193-201
23. Lleo A., Greenberg S.M., and Growdon J.H. Current pharmacotherapy for Alzheimer's disease. Annu. Rev. Med. 57 (2006) 513-533
24. Masliah E. The role of synaptic proteins in Alzheimer's disease. Ann. N.Y. Acad. Sci. 924 (2000) 68-75
25. Mehta P.D., Pirttila T., Mehta S.P., Sersen E.A., Aisen P.S., and Wisniewski H.M. Plasma and cerebrospinal fluid levels of amyloid beta proteins 1-40 and 1-42 in Alzheimer disease. Arch. Neurol. 57 (2000) 100-105
26. Moolman D.L., Vitolo O.V., Vonsattel J.P., and Shelanski M.L. Dendrite and dendritic spine alterations in Alzheimer models. J. Neurocytol. 33 (2004) 377-387
27. Motter R., Vigo-Pelfrey C., Kholodenko D., Barbour R., Johnson-Wood K., Galasko D., Chang L., Miller B., Clark C., Green R., et al. Reduction of beta-amyloid peptide42 in the cerebrospinal fluid of patients with Alzheimer's disease. Ann. Neurol. 38 (1995) 643-648
28. Oddo S., and LaFerla F.M. The role of nicotinic acetylcholine receptors in Alzheimer's disease. J. Physiol. Paris 99 (2006) 172-179
29. Pitschke M., Prior R., Haupt M., and Riesner D. Detection of single amyloid beta-protein aggregates in the cerebrospinal fluid of Alzheimer's patients by fluorescence correlation spectroscopy. Nat. Med. 4 (1998) 832-834
30. Podlisny M.B., Ostaszewski B.L., Squazzo S.L., Koo E.H., Rydell R.E., Teplow D.B., and Selkoe D.J. Aggregation of secreted amyloid beta-protein into sodium dodecyl sulfate-stable oligomers in cell culture. J. Biol. Chem. 270 (1995) 9564-9570
31. Probst A., Basler V., Bron B., and Ulrich J. Neuritic plaques in senile dementia of Alzheimer type: a Golgi analysis in the hippocampal region. Brain Res. 268 (1983) 249-254
32. Qi-Takahara Y., Morishima-Kawashima M., Tanimura Y., Dolios G., Hirotani N., Horikoshi Y., Kametani F., Maeda M., Saido T.C., Wang R., and Ihara Y. Longer forms of amyloid beta protein: implications for the mechanism of intramembrane cleavage by gamma-secretase. J. Neurosci. 25 (2005) 436-445
33. Rogawski M.A., and Wenk G.L. The neuropharmacological basis for the use of memantine in the treatment of Alzheimer's disease. CNS Drug Rev. 9 (2003) 275-308
34. Selkoe D.J. Alzheimer's disease is a synaptic failure. Science 298 (2002) 789-791
35. Selkoe D.J. The ups and downs of Abeta. Nat. Med. 12 (2006) 758-759
36. Shrestha B.R., Vitolo O.V., Joshi P., Lordkipanidze T., Shelanski M., and Dunaevsky A. Amyloid beta peptide adversely affects spine number and motility in hippocampal neurons. Mol. Cell Neurosci. 33 (2006) 274-282
37. Small D.H., and Cappai R. Alois Alzheimer and Alzheimer's disease: a centennial perspective. J. Neurochem. 99 (2006) 708-710
38. Snyder E.M., Nong Y., Almeida C.G., Paul S., Moran T., Choi E.Y., Nairn A.C., Salter M.W., Lombroso P.J., Gouras G.K., and Greengard P. Regulation of NMDA receptor trafficking by amyloid-beta. Nat. Neurosci. 8 (2005) 1051-1058
39. Sonkusare S.K., Kaul C.L., and Ramarao P. Dementia of Alzheimer's disease and other neurodegenerative disorders-memantine, a new hope. Pharmacol. Res. 51 (2005) 1-17
40. Spires T.L., Meyer-Luehmann M., Stern E.A., McLean P.J., Skoch J., Nguyen P.T., Bacskai B.J., and Hyman B.T. Dendritic spine abnormalities in amyloid precursor protein transgenic mice demonstrated by gene transfer and intravital multiphoton microscopy. J. Neurosci. 25 (2005) 7278-7287
41. Sze C.I., Troncoso J.C., Kawas C., Mouton P., Price D.L., and Martin L.J. Loss of the presynaptic vesicle protein synaptophysin in hippocampus correlates with cognitive decline in Alzheimer disease. J. Neuropathol. Exp. Neurol. 56 (1997) 933-944
42. Tanzi R.E. The synaptic Abeta hypothesis of Alzheimer disease. Nat. Neurosci. 8 (2005) 977-979
43. Townsend M., Shankar G.M., Mehta T., Walsh D.M., and Selkoe D.J. Effects of secreted oligomers of amyloid beta-protein on hippocampal synaptic plasticity: a potent role for trimers. J. Physiol. 572 (2006) 477-492
44. Walsh D.M., Klyubin I., Fadeeva J.V., Cullen W.K., Anwyl R., Wolfe M.S., Rowan M.J., and Selkoe D.J. Naturally secreted oligomers of amyloid beta protein potently inhibit hippocampal long-term potentiation in vivo. Nature 416 (2002) 535-539
45. Walsh D.M., Klyubin I., Fadeeva J.V., Rowan M.J., and Selkoe D.J. Amyloid-beta oligomers: their production, toxicity and therapeutic inhibition. Biochem. Soc. Trans. 30 (2002) 552-557
46. Wang H.W., Pasternak J.F., Kuo H., Ristic H., Lambert M.P., Chromy B., Viola K.L., Klein W.L., Stine W.B., Krafft G.A., and Trommer B.L. Soluble oligomers of beta amyloid (1-42) inhibit long-term potentiation but not long-term depression in rat dentate gyrus. Brain Res. 924 (2002) 133-140
47. Ziv N.E., and Smith S.J. Evidence for a role of dendritic filopodia in synaptogenesis and spine formation. Neuron 17 (1996) 91-102